We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Boston Scientific Suffers Losses Due to Shipment Hold on ICDs
Boston Scientific Suffers Losses Due to Shipment Hold on ICDs
April 30, 2010
A month-long shipment hold on implantable cardioverter defibrillators (ICD) and cardiac resynchronization therapy defibrillators is expected to cost Boston Scientific $300 million this year.